In the late stages of tumor, cancer cells produce high levels of TGF-β or exhibit altered TGF-β signaling that can aberrantly activate the EMT process to promote tumor cell migration and invasion, generation of CSCs and initiation of metastasis [16, 17]. This evidence concerns the gene TGFB1 and neoplasm.